Gastric-Outlet Obstruction Induced by Prostaglandin Therapy in Neonates

Abstract

The administration of prostaglandin E1 to neonates can cause gastric-outlet obstruction due to antral hyperplasia. Neonates who receive prostaglandin E1 at recommended doses for more than 120 hours should be closely monitored for evidence of antral hyperplasia.